Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
The current treatment for patients with hypothyroidism is levothyroxine (L-T4) along with normalization of serum thyroid-stimulating hormone (TSH). However, normalization of serum TSH with L-T4 monotherapy results in relatively low serum 3,5,3'-triiodothyronine (T3) and high serum thyroxine/T3 (T4/T3) ratio. In the hypothalamus-pituitary dyad as well as the rest of the brain, the majority of T3 present is generated locally by T4 deiodination via the type 2 deiodinase (D2); this pathway is self-limited by ubiquitination of D2 by the ubiquitin ligase WSB-1. Here, we determined that tissue-specific differences in D2 ubiquitination account for the high T4/T3 serum ratio in adult thyroidectomized (Tx) rats chronically implanted with subcutaneous L-T4 pellets. While L-T4 administration decreased whole-body D2-dependent T4 conversion to T3, D2 activity in the hypothalamus was only minimally affected by L-T4. In vivo studies in mice harboring an astrocyte-specific Wsb1 deletion as well as in vitro analysis of D2 ubiquitination driven by different tissue extracts indicated that D2 ubiquitination in the hypothalamus is relatively less. As a result, in contrast to other D2-expressing tissues, the hypothalamus is wired to have increased sensitivity to T4. These studies reveal that tissue-specific differences in D2 ubiquitination are an inherent property of the TRH/TSH feedback mechanism and indicate that only constant delivery of L-T4 and L-T3 fully normalizes T3-dependent metabolic markers and gene expression profiles in Tx rats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The regulation varies by tissue as the brain predominantly expresses type 2 deiodinase, whereas type 1 deiodinase is abundant in other tissues of the body, and by thyroid state, as T3 excess upregulates type 1 deiodinase but downregulates type 2 deiodinase, which is upregulated in hypothyroidism (57–64).”
From Homeostatic control of the thyroid-pituitary axis: perspectives for diagnosis and treatment (2015) · cites this paper as [64]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The regulation varies by tissue as the brain predominantly expresses type 2 deiodinase, whereas type 1 deiodinase is abundant in other tissues of the body, and by thyroid state, as T3 excess upregulates type 1 deiodinase but downregulates type 2 deiodinase, which is upregulated in hypothyroidism (57–64).”
From Homeostatic control of the thyroid-pituitary axis: perspectives for diagnosis and treatment (2015) · cites this paper as [64]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Levothyroxine-treated hypothyroidism is also associated with reduced tri-iodothyronine signalling in the liver and brain.176”
From Hypothyroidism (2024) · cites this paper as [176]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also in pituitary thyrotrophs, the loss of D2 activity caused by T4 is a much slower process [5].”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, there is a new understanding that, under certain conditions, T3 signaling may be compromised in a tissue-specific fashion while systemic thyroid function is preserved.”
From Emerging Therapies in Hypothyroidism (2024) · cites this paper as [25]
Experimental — accuracy not yet measured
22 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891
Self-citationhGFAP‐cre transgenic mice for manipulation of glial and neuronal function in vivo
Zhuo, L., Theis, M., Alvarez‐Maya, I., Brenner, M., Willecke, K., & Messing, A. (2001) · genesis · doi:10.1002/gene.10008 · Cited by 659
Bacteriophage P1 site-specific recombination
Sternberg, N., & Hamilton, D. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90375-2 · Cited by 579
Ciechanover, A., Heller, H., Elias, S., Haas, A. L., & Hershko, A. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1365 · Cited by 562
2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism
Wiersinga, W. M., Duntas, L., Fadeyev, V., Nygaard, B., & Vanderpump, M. P. J. (2012) · European Thyroid Journal · doi:10.1159/000339444 · Cited by 437
Research works printed but not linked: 3
- Bianco, 1988, Am J Physiol., 255, E496
- Tu, 1999, Endocrinology., 140, 784, 10.1210/endo.140.2.6486 · doi:10.1210/endo.140.2.6486 · Paper page
- Carvalho, 1993, Am J Physiol., 264, E874
Cited by
Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30703-1 · Cited by 1,159
Self-citationRole of Thyroid Hormones in Skeletal Development and Bone Maintenance
Bassett, J. H. D., & Williams, G. R. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1106 · Cited by 540
Deiodinases and their intricate role in thyroid hormone homeostasis
Luongo, C., Dentice, M., & Salvatore, D. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0218-2 · Cited by 332
Paradigms of dynamic control of thyroid hormone signaling
Bianco, A. C., Dumitrescu, A., Gereben, B., Ribeiro, M. O., Fonseca, T. L., Fernandes, G. W., & Bocco, B. M. L. C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00275 · Cited by 293
Self-citationNew insights into thyroid hormone action
Mendoza, A., & Hollenberg, A. N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.012 · Cited by 281
“Within the brain, the hypothalamus D2 activity is not sensitive to T4, whereas the hippocampus and cortex showed increased D2 activity in astrocyte-specific WSB-1-KO mice (Werneck-de-Castro et al., 2015).”
An Online Survey of Hypothyroid Patients Demonstrates Prominent Dissatisfaction
Peterson, S. J., Cappola, A. R., Castro, M. R., Dayan, C. M., Farwell, A. P., Hennessey, J. V., Kopp, P. A., Ross, D. S., Samuels, M. H., Sawka, A. M., et al. (2018) · Thyroid · doi:10.1089/thy.2017.0681 · Cited by 231
“This could result from differences in D2 regulation between the hypothalamus and peripheral tissues, as has been shown in a hypothyroid rat model (20).”
Self-citationThe molecular basis of the non-thyroidal illness syndrome
de Vries, E. M., Fliers, E., & Boelen, A. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0133 · Cited by 192
Is a Normal TSH Synonymous With “Euthyroidism” in Levothyroxine Monotherapy?
Peterson, S. J., McAninch, E. A., & Bianco, A. C. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2660 · Cited by 182
“Thyroidectomized rodents treated with LT4 at doses that normalize serum TSH exhibit relatively lower serum T3 and higher serum T4 levels as well as markers of hypothyroidism within their brain, skeletal muscle, and liver tissues (10, 11).”
BackgroundSelf-citationJonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · Thyroid® · doi:10.1089/thy.2020.0720 · Cited by 172
“’’ Use of combination therapy with both LT4 and LT3 in hypothyroid rats also normalized serum TSH but additionally allowed the T3 deficit in peripheral tissues to be redressed (4).”
InfluentialSelf-citationPrimary hypothyroidism and quality of life
Hegedüs, L., Bianco, A. C., Jonklaas, J., Pearce, S. H., Weetman, A. P., & Perros, P. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00625-8 · Cited by 144
Self-citationHomeostatic control of the thyroid-pituitary axis: perspectives for diagnosis and treatment
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00177 · Cited by 143
Scope and limitations of iodothyronine deiodinases in hypothyroidism
Gereben, B., McAninch, E. A., Ribeiro, M. O., & Bianco, A. C. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.155 · Cited by 146
“These issues have were confirmed in an animal study in which thyroidectomized rats receiving levothyroxine monotherapy exhibited low levels of serum T3 and a high T4:T3 ratio.(17) The novelty of this study was not only that these abnormalities in systemic parameters were confirmed but also that tissue-specific markers…”
BackgroundResultInfluentialSelf-citationTaylor, P. N., Medici, M. M., Hubalewska-Dydejczyk, A., & Boelaert, K. (2024) · The Lancet · doi:10.1016/s0140-6736(24)01614-3 · Cited by 128
The history and future of treatment of hypothyroidism
McAninch, E. A., & Bianco, A. C. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1799 · Cited by 118
“Yet, the brain, liver, and skeletal muscle tissues of these L-thyroxine–treated animals continue to exhibit markers of hypothyroidism (9), probably because of the inability of L-thyroxine monotherapy to restore tissue levels of T3 (8).”
InfluentialSelf-citationType 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain
Jo, S., Fonseca, T. L., Bocco, B. M. L. C., Fernandes, G. W., McAninch, E. A., Bolin, A. P., Da Conceição, R. R., Werneck-de-Castro, J. P., Ignacio, D. L., Egri, P., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci123176 · Cited by 107
Self-citationThe Deiodinase Trio and Thyroid Hormone Signaling
Bianco, A. C., & da Conceição, R. R. (2018) · Methods in Molecular Biology · doi:10.1007/978-1-4939-7902-8_8 · Cited by 96
“An example of how D2 ubiquitination plays important physiological roles is the existence of tissue-specific differences in D2 ubiquitination [39].”
BackgroundSelf-citationMcAninch, E. A., Rajan, K. B., Miller, C. H., & Bianco, A. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01361 · Cited by 94
Self-citationBiochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy
Ito, M., Miyauchi, A., Hisakado, M., Yoshioka, W., Ide, A., Kudo, T., Nishihara, E., Kihara, M., Ito, Y., Kobayashi, K., et al. (2017) · Thyroid · doi:10.1089/thy.2016.0426 · Cited by 91
“(7) observed a significant change in LDL-C and no significant change in TG because of differences in the mechanism of action of thyroid hormone on LDL-C and TG levels.”
BackgroundResultInfluentialOptimal thyroid hormone replacement
Jonklaas, J. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab031 · Cited by 89
Mitchell, A. L., Hegedüs, L., Žarković, M., Hickey, J. L., & Perros, P. (2021) · Clinical Endocrinology · doi:10.1111/cen.14340 · Cited by 81
Jonklaas, J., Bianco, A. C., Cappola, A. R., Celi, F. S., Fliers, E., Heuer, H., McAninch, E. A., Moeller, L. C., Nygaard, B., Sawka, A. M., et al. (2021) · European Thyroid Journal · doi:10.1159/000512970 · Cited by 78
Self-citationIndividualized Therapy for Hypothyroidism: Is T4 Enough for Everyone?
Ettleson, M. D., & Bianco, A. C. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa430 · Cited by 75
Self-citationHoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00364 · Cited by 69
“This was, however, done in rodents where various tissues remained in the hypothyroid state on LT4 monotherapy despite normal serum TSH levels, and only T3/ T4 combination could restore euthyroidism in tissues (91, 92).”
BackgroundMohammadi, S., Dolatshahi, M., & Rahmani, F. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01314-5 · Cited by 71
“Finally, tissue specific differences in type 2 iodothyronine deiodinase ubiquitination mediated by WSB1 can control tissue specific rate of T4–T3 conversion in thyroidectomized rats [117].”
BackgroundT3 levels and thyroid hormone signaling
Salas-Lucia, F., & Bianco, A. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1044691 · Cited by 66
“Subsequent studies using a similar rat model obtained direct evidence of tissue hypothyroidism in LT4-treated rats at doses that normalized TSH levels (77).”
BackgroundSelf-citationPerros, P., Van Der Feltz‐Cornelis, C., Papini, E., Nagy, E. V., Weetman, A. P., & Hegedüs, L. (2023) · Clinical Endocrinology · doi:10.1111/cen.14473 · Cited by 65
Thyroxine and treatment of hypothyroidism: seven decades of experience
Mateo, R. C. I., & Hennessey, J. V. (2019) · Endocrine · doi:10.1007/s12020-019-02006-8 · Cited by 57
“Relatively low serum T3 levels have been suggested to contribute to residual manifestations attributed to persistent hypothyroidism, however others have speculated that the higher serum T4:T3 ratio might impair systemic T3 production via downregulation of a deiodinase pathway, although this has not been definitively d…”
BackgroundKu, E. J., Yoo, W. S., Lee, E. K., Ahn, H. Y., Woo, S. H., Hong, J. H., Chung, H. K., & Park, J.-W. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab539 · Cited by 57
THERAPY OF ENDOCRINE DISEASE: T4 + T3 combination therapy: is there a true effect?
Wiersinga, W. M. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0645 · Cited by 52
Joseph‐Bravo, P., Jaimes-Hoy, L., & Charli, J. (2016) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9375-y · Cited by 56
Hennessey, J. V., & Espaillat, R. (2018) · International Journal of Clinical Practice · doi:10.1111/ijcp.13062 · Cited by 49
Brain Fog in Hypothyroidism: What Is It, How Is It Measured, and What Can Be Done About It
Samuels, M. H., & Bernstein, L. J. (2022) · Thyroid · doi:10.1089/thy.2022.0139 · Cited by 64
“If the rats are treated with combined LT4/LT3, DIO2 activity in the cortex and hippocampus is restored, and T3-responsive gene expression nor-malizes (52).”
Relational Stability in the Expression of Normality, Variation, and Control of Thyroid Function
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00142 · Cited by 48
Kouidhi, S., & Clerget-Froidevaux, M.-S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072017 · Cited by 50
“D2 is both expressed at the peripheral and central levels [56,57].”
BackgroundBiondi, B., Bartalena, L., Chiovato, L., Lenzi, A., Mariotti, S., Pacini, F., Pontecorvi, A., Vitti, P., & Trimarchi, F. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0511-z · Cited by 44
Wu, Z., Martinez, M. E., Germain, D. L. S., & Hernández, A. (2016) · Endocrinology · doi:10.1210/en.2016-1680 · Cited by 45
Jonklaas, J., & Burman, K. D. (2016) · Thyroid® · doi:10.1089/thy.2015.0629 · Cited by 41
“Areas of uncertainty are whether quality of life is decreased in patients with hypothyroidism who are taking levothyroxine (LT4) monotherapy (1-5), whether the inherent problem with LT4 monotherapy is the failure of deiodinases to adequately compensate for the high thyroxine (T4)/triiodothyronine (T3) ratio in athyreo…”
Physician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics
Jonklaas, J., Tefera, E., & Shara, N. (2018) · Thyroid · doi:10.1089/thy.2018.0325 · Cited by 41
“(27), regarding the consequences of deiodinase polymorphisms or impairment of deiodinase function, albeit mostly in animal studies (28), retrospective or cross-sectional rather than prospective studies (29–31), or small studies (30).”
BackgroundIndividualised requirements for optimum treatment of hypothyroidism: complex needs, limited options
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2019) · Drugs in Context · doi:10.7573/dic.212597 · Cited by 41
Astrocytes in neuroendocrine systems: An overview
MacDonald, A. J., Robb, J. L., Morrissey, N. A., Beall, C., & Ellacott, K. L. J. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12726 · Cited by 43
“hypothalamus to maintain higher sensitivity to T4 (78).”
BackgroundNew insights into the variable effectiveness of levothyroxine monotherapy for hypothyroidism
McAninch, E. A., & Bianco, A. C. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00325-3 · Cited by 39
Self-citationPersistent hypothyroid symptoms in a patient with a normal thyroid stimulating hormone level
Jonklaas, J. (2017) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000355 · Cited by 38
Das, D., Banerjee, A., Jena, A. B., Duttaroy, A. K., & Pathak, S. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112613 · Cited by 50
Emerging Therapies in Hypothyroidism
Bianco, A. C. (2024) · Annual Review of Medicine · doi:10.1146/annurev-med-060622-101007 · Cited by 44
Self-citationSex Dimorphic Responses of the Hypothalamus-Pituitary-Thyroid Axis to Energy Demands and Stress
de, M. A. P.-M., Sotelo-Rivera, I., Gutiérrez-Mata, A., Charli, J., & Joseph‐Bravo, P. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.746924 · Cited by 42
“T3 negative feedback effects include other elements of the axis; TH stimulate TRH-DE activity and expression in tanycytes (11), the activity of the two enzymes that can degrade T3, Dio1 and Dio3, whereas they inhibit the expression of Dio2 in pituitary but not in tanycytes (27, 28).”
BackgroundHoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2016) · European Thyroid Journal · doi:10.1159/000447967 · Cited by 35
T4 + T3 combination therapy: any progress?
Wiersinga, W. M. (2019) · Endocrine · doi:10.1007/s12020-019-02052-2 · Cited by 35
The role of functional thyroid capacity in pituitary thyroid feedback regulation
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13003 · Cited by 35
“However, experiments in rodents investigating locally expressed T3‐dependent metabolic markers and gene profiles confirmed a breakdown of peripheral autoregulation in various tissues, preventable by T3 addition rather than TSH normalisation with LT4.(48) In conclusion, functional thyroid reserve impacts on hypothalami…”
BackgroundDefining optimal health range for thyroid function based on the risk of cardiovascular disease
Chaker, L., Korevaar, T. I. M., Rizopoulos, D., Collet, T.-H., Völzke, H., Hofman, A., Rodondi, N., Cappola, A. R., Peeters, R. P., & Franco, O. H. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00410 · Cited by 33
“One explanation could be that in euthyroid subjects, TSH predominantly reflects the pituitary-thyroid axis set point rather than disease risk (29), whereas independent of TSH, circulating FT4 (and subsequently free triiodothyronine acting intracellularly) represents the bioavailable thyroid hormone that can be taken u…”
BackgroundAxonal T3 uptake and transport can trigger thyroid hormone signaling in the brain
Salas-Lucia, F., Fekete, C., Sinkó, R., Egri, P., Rada, K., Ruska, Y., Gereben, B., & Bianco, A. C. (2023) · eLife · doi:10.7554/elife.82683 · Cited by 33
Self-citationThe Processes of Anterior Pituitary Hormone Pulse Generation
Tissier, P. L., Fiordelisio, T., & Mollard, P. (2018) · Endocrinology · doi:10.1210/en.2018-00508 · Cited by 36
“Again the thyroid 15 axis provides an excellent example of this, since feedback to the hypothalamus is 16 dependent on active transport of thyroid hormone at the level of the median eminence 17 (60) but is enhanced by post-translational modification of type 2 deiodinase (61).”
BackgroundMidgley, J. E. M., Larisch, R., Dietrich, J. W., & Hoermann, R. (2015) · Endocrine Connections · doi:10.1530/ec-150056 · Cited by 31
“This study suggest ubiquitination may be the limiting factor for T4 283 alone to restore true tissue euthyroidism in the rodent (29).”
BackgroundSustained release T3 therapy: animal models and translational applications
Idrees, T., Price, J. D., Piccariello, T., & Bianco, A. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00544 · Cited by 30
“Preclinical studies of LT4-treated thyroidectomized rats indicate that minimally reduced plasma T3 levels are sufficient to cause widespread dampening in TH signaling, including in the liver, skeletal muscle and brain (24).”
BackgroundSelf-citationRisks and safety of combination therapy for hypothyroidism
Jonklaas, J. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2016.1182019 · Cited by 27
DiStefano, J., & Jonklaas, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00746 · Cited by 28
“Furthermore, animal studies suggest T3 deficiency at the tissue level with LT4 therapy alone (7, 8).”
BackgroundSerum thyrotropin and triiodothyronine levels in levothyroxine-treated patients
Ettleson, M. D., Prieto, W. H., Russo, P. S. T., de Sa, J., Wan, W., Laiteerapong, N., Maciel, R. M. B., & Bianco, A. C. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac725 · Cited by 25
Self-citationUpdate on the treatment of hypothyroidism
Jonklaas, J. (2016) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000242 · Cited by 27
The Swinging Pendulum in Treatment for Hypothyroidism: From (and Toward?) Combination Therapy
McAninch, E. A., & Bianco, A. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00446 · Cited by 24
“Yet, the brain, liver and skeletal muscle tissues of these LT4-treated animals exhibit markers of localized hypothyroidism (29), likely due the inability of LT4 monotherapy to restore tissue levels of T3 (30).”
BackgroundInfluentialSelf-citationDa Conceição, R. R., Fernandes, G. W., Fonseca, T. L., Bocco, B. M. L. C., & Bianco, A. C. (2018) · Thyroid · doi:10.1089/thy.2018.0205 · Cited by 23
“Later, it was verified that LT4-treated hypothyroid rats with a normal serum TSH exhibit signs of hypothyroidism in the liver, skeletal muscle, and brain, which are normalized with therapy containing both LT4 and LT3 (8).”
InfluentialSelf-citationBank, J. H. H., Cubuk, C., Wilson, D., Rijntjes, E., Kemmling, J., Markowsky, H., Barrett, P., & Herwig, A. (2017) · Journal of Comparative Physiology B · doi:10.1007/s00360-017-1086-5 · Cited by 25
Patient Experiences and Perceptions Associated with the Use of Desiccated Thyroid Extract
Toloza, F. J. K., Espinoza Suarez, N. R., El Kawkgi, O., Golembiewski, E. H., Ponce, O. J., Yao, L., Maraka, S., Singh Ospina, N. M., & Brito, J. P. (2020) · Medicina · doi:10.3390/medicina56040161 · Cited by 22
Regulation of Thyroid Function, Synthesis, and Function of Thyroid Hormones
Visser, T. J. (2018) · Endocrinology · doi:10.1007/978-3-319-45013-1_1 · Cited by 24
“Ferrocrinology”—Iron Is an Important Factor Involved in Gluco- and Lipocrinology
Szklarz, M., Gontarz-Nowak, K., Matuszewski, W., & Bandurska-Stankiewicz, E. M. (2022) · Nutrients · doi:10.3390/nu14214693 · Cited by 22
“In a study of pregnant women, higher cortisol levels were seen in ID versus control subjects [49].”
BackgroundYounis, I. R., AHMED, M. A., Burman, K. D., Soldin, O. P., & Jonklaas, J. (2018) · Thyroid · doi:10.1089/thy.2017.0380 · Cited by 22
“Although this may be a simplification, at least in animal models (34), it is assumed that all other clinical effects of thyroid hormone in patients receiving LT4 replacement parallel its effect on the hypothalamus, so that TSH can provide a quantitative measure of the adequacy of LT4 replacement.”
BackgroundCombination Thyroid Hormone Replacement; Knowns and Unknowns
Taylor, P. N., Eligar, V., Muller, I., Scholz, A., Dayan, C., & Okosieme, O. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00706 · Cited by 21
“Normalization of tissue thyroid status in murine studies was achieved using slow release pellets of T4 and T3 (25).”
BackgroundInfluentialDumitrescu, A. M., Hanlon, E. C., Arosemena, M., Duchon, O., Ettleson, M., Giurcanu, M., & Bianco, A. C. (2022) · Thyroid · doi:10.1089/thy.2021.0304 · Cited by 20
“In LT4-treated thyroidectomized rats, tissue euthyroidism only occurs after normalization of serum T3 (15).”
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2018) · Journal of Thyroid Research · doi:10.1155/2018/3239197 · Cited by 20
Sustained Pituitary T3 Production Explains the T4-mediated TSH Feedback Mechanism
Batistuzzo, A., Salas-Lucia, F., Gereben, B., Ribeiro, M. O., & Bianco, A. C. (2023) · Endocrinology · doi:10.1210/endocr/bqad155 · Cited by 18
“Nonetheless, our previous studies suggest that in this location as well, D2 is poorly ubiquitinated (60).”
Self-citationCasula, S., Ettleson, M. D., & Bianco, A. C. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.04.003 · Cited by 21
Self-citationA Transgenic Mouse Model for Detection of Tissue-Specific Thyroid Hormone Action
Mohácsik, P., Erdélyi, F., Baranyi, M., Botz, B., Szabó, G., Tóth, M., Haltrich, I., Helyes, Z., Sperlágh, B., Tóth, Z., et al. (2017) · Endocrinology · doi:10.1210/en.2017-00582 · Cited by 22
“Tissue specificity of TH action could also explain why some hypothyroid patients remain symptomatic despite exhibiting normal plasma thyroid-stimulating hormone levels (14, 15).”
BackgroundSelf-citationThyroid function related symptoms during levothyroxine monotherapy in athyreotic patients
Ito, M., Miyauchi, A., Hisakado, M., Yoshioka, W., Kudo, T., Nishihara, E., Kihara, M., Ito, Y., Miya, A., Fukata, S., et al. (2019) · Endocrine Journal · doi:10.1507/endocrj.ej19-0094 · Cited by 17
Idrees, T., Prieto, W. H., Casula, S., Ajith, A., Ettleson, M., Narchi, F. A. A., Russo, P. S. T., Fernandes, F., Johnson, J., Mayampurath, A., et al. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab038 · Cited by 17
“In addition, preclinical findings in LT4-treated thyroidectomized rats indicate that serum cholesterol remains above the reference range despite normalization of serum TSH [10].”
BackgroundSelf-citationThyroid Hormone Homeostasis in Levothyroxine-treated Patients: Findings From ELSA-Brasil
Penna, G. C., Bensenor, I. M., Bianco, A. C., & Ettleson, M. D. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae139 · Cited by 16
Self-citationIdentification of Resistance to Exogenous Thyroxine in Humans
Lacámara, N., Beatriz Lecumberri, S., Barquiel, B., Escribano, A., Casado, I. G., Álvarez‐Escolá, C., Blanquer, F. A., Morales, F., Alfayate, R., Bernal-Soriano, M. C., et al. (2020) · Thyroid · doi:10.1089/thy.2019.0825 · Cited by 17
“Further, D2 activity is tightly regulated by ubiquitination and deubiquitination, controlling the active half-life of the enzyme in the endoplasmic reticulum (54).”
Treatment Preferences in Patients With Hypothyroidism
de Lima Beltrão, F. E., Carvalhal, G., de Almeida Beltrão, D. C., de Lima Beltrão, F. E., Ribeiro, M. O., Ettleson, M. D., Ramos, H. E., & Bianco, A. C. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae651 · Cited by 16
Self-citationIto, M., Kawasaki, M., Danno, H., Kohsaka, K., Nakamura, T., Hisakado, M., Yoshioka, W., Kasahara, T., Kudo, T., Nishihara, E., et al. (2019) · Thyroid · doi:10.1089/thy.2019.0135 · Cited by 18
“reported that a combination of high serum T4 and low serum T3 levels during T4 monotherapy rats had consequences for thyroid hormone action, as reflected in the brain, liver, and skeletal muscle, all of which exhibited indications of hypothyroidism despite normal serum TSH levels (20).”
BackgroundBiondi, B., Pucci, M., Pontieri, G., Formisano, P., & Esposito, R. (2023) · Thyroid · doi:10.1089/thy.2023.0135 · Cited by 15
Hoermann, R., Pekker, M. J., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13192 · Cited by 14
Berghoff, A. S., Wippel, C., Starzer, A. M., Ballarini, N. M., Wolpert, F., Bergen, E. S., Wolf, P. S., Steindl, A., Widhalm, G., Gatterbauer, B., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.05.011 · Cited by 14
“the combination of levothyroxine (T4) plus liothyronine (T3) could normalize mitochondrial content and aglycerophosphate dehydrogenase activity e both markers of T3-responsiveness in the liver and skeletal muscle e and circulating cholesterol concentrations better than levothyroxine (T4) treatment alone [22].”
BackgroundRegulation of Thyroid Function, Synthesis and Function of Thyroid Hormones
Visser, T. J. (2018) · Endocrinology · doi:10.1007/978-3-319-29195-6_1-1 · Cited by 28
Chamas, L., Seugnet, I., Poirier, R., Clerget-Froidevaux, M.-S., & Enderlin, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911938 · Cited by 19
Hoermann, R., Midgley, J. E. M., Dietrich, J. W., & Larisch, R. (2017) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018817716401 · Cited by 14
Biondi, B. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02302 · Cited by 17
Mele, C., Tagliaferri, A., Pagano, L., Soranna, D., Scacchi, M., Aimaretti, G., Biondi, B., & Marzullo, P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00773 · Cited by 15
Predictors of Improvement in Quality of Life When Treating Hypothyroidism
Medici, B. B., la Cour, J. L., Knop, F. K., Krakauer, M., Michaelsson, L. F., Faber, J. O., Watt, T., & Nygaard, B. (2021) · Journal of Thyroid Research · doi:10.1155/2021/5577217 · Cited by 14
Sun, Y. J., Du, X., Shan, Z., Teng, W., & Jiang, Y. (2021) · British Journal Of Nutrition · doi:10.1017/s0007114521002592 · Cited by 12
“The production of T3 catalysed by Dio2 occurs inside the cell and increases TH signals, while a decrease in Dio2 activity or reduction of Dio2 gene expression causes local hypothyroidism(10).”
BackgroundMethodResultLiu, Y., Milanesi, A., & Brent, G. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813814-4.00021-3 · Cited by 15
Jonklaas, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.934003 · Cited by 13
“Biomarkers of euthyroidism that could reveal this tissue hypothyroidism have been investigated in animal studies (19, 20), but have not been studied in a rigorous manner in humans and deserve further”
BackgroundLuongo, C., De Stefano, M. A., Ambrosio, R., Volpe, F., Porcelli, T., Golia, V., Bellevicine, C., Troncone, G., Masone, S., Damiano, V., et al. (2023) · Thyroid · doi:10.1089/thy.2022.0472 · Cited by 11
“26 Furthermore, some T3 generated by D2 in mediobasal hypothalamic tanycytes, also reaches the pituitary through the portal capillaries contributing to the pituitary T3 content.”
Variable transduction of thyroid hormone signaling in structures of the mouse brain
Sinkó, R., Salas-Lucia, F., Mohácsik, P., Halmos, E., Wittmann, G., Egri, P., Bocco, B. M. L. C., Batistuzzo, A., Fonseca, T. L., Fekete, C., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2415970122 · Cited by 13
“A possibility raised by these results is that, in tanycytes, D2 is less susceptible to ubiquitination and/or proteasomal degradation, as shown in vitro using hypothalamic extracts ( 35 ).”
Self-citationLevothyroxine therapy in thyroidectomized patients: ongoing challenges and controversies
Rossi, L., Paternoster, M., Cammarata, M., Bakkar, S. Y., & Miccoli, P. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1582734 · Cited by 16
LT4 and Slow Release T3 Combination: Optimum Therapy for Hypothyroidism?
Azizi, F., Amouzegar, A., Mehran, L., & Abdi, H. (2020) · Intern J Endocrinol Metab · doi:10.5812/ijem.100870 · Cited by 14
“There exists some evidence that during LT4+LT3 therapy, the normal TSH concentration is accompanied by the euthyroid state in various tissues (29).”
BackgroundZhang, H., Tong, W., Zeng, W., Luo, H., Zhang, L., Feng, J., Xiao, Y., & Wang, G. A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1627787 · Cited by 19
Hypothyreose – wann und wie behandeln?
Koehler, V. F., Reincke, M., & Spitzweg, C. (2018) · Der Internist · doi:10.1007/s00108-018-0438-x · Cited by 14
Razvi, S., Ryan, V., Ingoe, L. E., Pearce, S. H. S., & Wilkes, S. (2019) · European Thyroid Journal · doi:10.1159/000504047 · Cited by 16
Stanculescu, D., Larsson, L., & Bergquist, J. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.672370 · Cited by 10
Temporal Pole Responds to Subtle Changes in Local Thyroid Hormone Signaling
Marcelino, C. P., McAninch, E. A., Fernandes, G. W., Bocco, B. M. L. C., Ribeiro, M. O., & Bianco, A. C. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa136 · Cited by 9
“On the other hand, studies of T3-responsive genes in LT4-treated hypothyroid rats with normal thyrotropin (thyroid-stimulating hormone) indicate that the minimal reduction in plasma T3 leads to brain hypothyroidism [27].”
BackgroundSelf-citationTriiodothyronine alongside levothyroxine in the management of hypothyroidism?
Gottwald-Hostalek, U., & Kahaly, G. J. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1984219 · Cited by 9
“45 DB, XO (8) 2016 32 75/15 (5:1) Combination therapy increased heart rate and reduced FT4 with no change in T3 vs.”
BackgroundPhan, G. Q., Yavuz, S., Stamatouli, A. M., Madan, R., Chen, S., Grover, A. C., Nilubol, N., Bedoya, P., Trankle, C. R., Markley, R., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1522753 · Cited by 9
Hoermann, R., Midgley, J. E. M., Larisch, R., & Dietrich, J. W. (2020) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2020.100219 · Cited by 12
“Intracellular T3 levels, which could only be measured in experimental animals, were equally found to be inadequate in various tissues despite TSH normalisation on LT4 replacement [35,36].”
Background
Metadata
- Authors
- Werneck de Castro, J. P., Fonseca, T. L., Ueta, C. B., McAninch, E. A., Abdalla, S., Wittmann, G., Lechan, R. M., Gereben, B., & Bianco, A. C.
- Affiliations
- Rush University Medical Center (US)
- University of Miami (US)
- Tufts University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2015-01-02
- Volume
- 125
- Issue
- 2
- Pages
- 769-781
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4319436
- OpenAlex
- W2134856350
- Cited by
- 184
- References
- 62
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 11 · 2023: 14 · 2022: 20 · 2021: 20 · 2020: 16 · 2019: 19 · 2018: 16 · 2017: 15 · 2016: 14 · 2015: 6
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK077148)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- type 2 deiodinase, hypothalamus, triiodothyronine, T4/T3 ratio, levothyroxine, thyroidectomy, astrocytes, hypothyroidism treatment
- MeSH terms
- Iodothyronine Deiodinase Type II, Animals, Humans, Hypothalamo-Hypophyseal System, Hypothyroidism, Iodide Peroxidase, Thyrotropin, Thyroxine, Gene Expression Regulation, Enzymologic, Gene Deletion, Mice, Knockout, Ubiquitin-Protein Ligases, Intracellular Signaling Peptides and Proteins, Mice, Rats, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.